Hamps Bio Limited, a company listed on the Bombay Stock Exchange (BSE) under the scrip code 544312, has announced a revision to the record date for its proposed bonus equity share issue. The company has changed the record date from September 8, 2025, to September 9, 2025, following communication from the BSE.

Bonus Share Details

The company plans to issue bonus shares in a 1:1 ratio, meaning shareholders will receive:

• One bonus equity share of Rs. 10 each
• For every one existing fully paid-up equity share of Rs. 10 each

This bonus share issuance was approved by shareholders through an ordinary resolution at the company's 18th Annual General Meeting held on August 30, 2025.

Revised Record Date

The revision in the record date was made in response to an email received from the Bombay Stock Exchange on September 5, 2025.

Company Background

Hamps Bio Limited, previously known as Hamps Bio Pvt. Ltd., is identified by the Corporate Identification Number (CIN) L24233GJ2007PLC049692. The company operates two manufacturing units:

1. Unit-1: Located at 2900/112, G.I.D.C. Industrial Estate, Nr. Atul Ltd., Ankleshwar - 393002
2. Unit-2: Situated at Plot No. C1-B-108, Nr- Mama Bhanja Factory, Bhatpore G.I.D.C., Surat, Gujarat, India 394510

Management Statement

Herrik Mountbaton Shah, the Managing Director & Chairman of Hamps Bio Limited, signed the official communication to the BSE regarding the record date revision. The company has requested the stock exchange to acknowledge and update their records accordingly.

Investors and shareholders of Hamps Bio Limited should take note of this revised record date for the upcoming bonus share issue. As always, it is advisable for stakeholders to keep track of official company announcements and consult with financial advisors for any investment-related decisions.

Hamps Bio Limited , a prominent player in the biotech industry, has announced significant changes to its board composition and committee structure. The company has appointed Ms. Shivali Rajpurohit as an Additional Director in the category of Non-Executive Independent Director, effective August 25, 2025, subject to shareholder approval.

New Independent Director Appointment

Ms. Shivali Rajpurohit brings a wealth of experience to her new role at Hamps Bio Limited. She is a qualified Company Secretary with a degree in law (LL.B) and specializes in corporate laws, secretarial compliance, including Companies Act, SEBI Regulations, Legal Documentation, Regulatory Filings, and Governance Framework. With over two years of experience handling legal and secretarial matters for both listed and unlisted entities, Ms. Rajpurohit is well-equipped to contribute to the company's governance and compliance efforts.

The appointment is for a five-year term, commencing from August 25, 2025, pending approval from the company's shareholders. Ms. Rajpurohit is not related to any existing directors of Hamps Bio Limited and is not debarred from holding directorship positions by SEBI or any other authority.

Board Committee Reconstitution

Following Ms. Rajpurohit's appointment, Hamps Bio Limited has announced a significant reshuffle of its board committees:

Audit Committee

• Chairperson: Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
• Members:
  • Ms. Shivali Rajpurohit (Independent Non-Executive Director)
  • Mrs. Pallavi Herrik Shah (Non-Executive Director)

Nomination and Remuneration Committee

• Chairperson: Ms. Shivali Rajpurohit (Independent Non-Executive Director)
• Members:
  • Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
  • Mrs. Pallavi Herrik Shah (Non-Executive Director)

Stakeholders Relationship Committee

• Chairperson: Mrs. Pallavi Herrik Shah (Non-Executive Director)
• Members:
  • Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
  • Ms. Shivali Rajpurohit (Independent Non-Executive Director)

These changes in the board composition and committee structure are aimed at enhancing the company's corporate governance practices and ensuring compliance with regulatory requirements.

The appointment of Ms. Rajpurohit and the reconstitution of board committees reflect Hamps Bio Limited's commitment to maintaining a strong and diverse leadership team. These strategic moves are expected to bring fresh perspectives and strengthen the company's decision-making processes in the dynamic biotech industry.